Wetzel Investment Advisors’s Vanguard Total International Stock ETF VXUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.6M Sell
163,993
-7,269
-4% -$577K 5.03% 5
2025
Q4
$12.9M Sell
171,262
-10,708
-6% -$800K 5.23% 5
2025
Q3
$13.4M Sell
181,970
-2,298
-1% -$163K 5.7% 5
2025
Q2
$12.7M Sell
184,268
-73,289
-28% -$4.76M 5.82% 6
2025
Q1
$16M Sell
257,557
-1,791
-0.7% -$111K 8.06% 1
2024
Q4
$15.3M Buy
259,348
+913
+0.4% +$56.6K 7.6% 2
2024
Q3
$16.7M Buy
258,435
+209,531
+428% +$13M 8.41% 1
2024
Q2
$2.95M Buy
48,904
+1,026
+2% +$62K 1.69% 15
2024
Q1
$2.77M Buy
47,878
+3,094
+7% +$180K 1.63% 15
2023
Q4
$2.6M Buy
+44,784
New +$2.45M 1.59% 16

Other funds holding VXUS

Wetzel Investment Advisors's VXUS Position: Q1 2026 in Review

Wetzel Investment Advisors reduced its Vanguard Total International Stock ETF (VXUS) stake by 4.2% in Q1 2026, selling an estimated $577K and leaving 163,993 shares worth $12.6M. The position accounts for 5.03% of the portfolio, ranked #5.

Wetzel Investment Advisors first reported a position in VXUS in Q4 2023 and has held it in 10 quarters since. The position peaked at $16.7M in Q3 2024. 1,713 funds tracked by Wall St. Rank hold VXUS as of Q1 2026.

  • Wetzel Investment Advisors held 163,993 shares of Vanguard Total International Stock ETF worth $12.6M as of Q1 2026.
  • Wetzel Investment Advisors sold 7,269 Vanguard Total International Stock ETF shares in Q1 2026, an estimated $577K.
  • Vanguard Total International Stock ETF made up 5.03% of Wetzel Investment Advisors's portfolio in Q1 2026, its #5 holding.
  • Wetzel Investment Advisors first reported a position in Vanguard Total International Stock ETF in Q4 2023 and has held it in 10 quarters since.
  • Wetzel Investment Advisors's Vanguard Total International Stock ETF position peaked at $16.7M in Q3 2024.
  • 1,713 funds tracked by Wall St. Rank held Vanguard Total International Stock ETF as of Q1 2026.

Based on Wetzel Investment Advisors's 13F filing for Q1 2026, filed 22 Apr 2026.